Mateos-Mazon, Juan <br/><br/>
Use of bortezomib in the management of chronic graft-versus-host disease among multiple myeloma patients relapsing after allogeneic transplantation.  [electronic resource] 

 -  Haematologica  Sep 2007 
 - 1295-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Letter 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.10820  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Boronic Acids--therapeutic use<br/>Bortezomib<br/>Female<br/>Follow-Up Studies<br/>Graft vs Host Disease--prevention & control<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--complications<br/>Neoplasm Recurrence, Local--drug therapy<br/>Pyrazines--therapeutic use<br/>Salvage Therapy<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous<br/>Treatment Outcome